![Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure](https://f6publishing.blob.core.windows.net/eb1091a4-8a64-41e0-b863-37d3e2f8a976/WJG-28-6258-g001.png)
Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure
![Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives | SpringerLink Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13668-022-00433-0/MediaObjects/13668_2022_433_Fig1_HTML.png)
Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives | SpringerLink
![Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms | Arteriosclerosis, Thrombosis, and Vascular Biology Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/76e2a1c0-8610-44b7-870e-f8b07b59cb28/1565ga1.jpg)
Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms | Arteriosclerosis, Thrombosis, and Vascular Biology
![Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate Induced Mouse Colitis Models | Journal of Medicinal Chemistry Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate Induced Mouse Colitis Models | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b00768/asset/images/large/jm-2017-007687_0001.jpeg)
Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate Induced Mouse Colitis Models | Journal of Medicinal Chemistry
![PDF] The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. | Semantic Scholar PDF] The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f160ef061d89b9271c8fb2c2919603cda06de944/6-Figure1-1.png)
PDF] The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. | Semantic Scholar
![Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy](https://c8.alamy.com/comp/DMK3KK/glucagon-like-peptide-2-glp-2-peptide-molecule-its-recombinant-analog-DMK3KK.jpg)
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy
![Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome | Journal of Pharmacology and Experimental Therapeutics Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/373/2/193/F1.large.jpg)
Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome | Journal of Pharmacology and Experimental Therapeutics
![PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cfd69eccd23a9c8a10ba8cd828f6dc1685055d28/5-Figure1-1.png)
PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar
![Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives | SpringerLink Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13668-022-00433-0/MediaObjects/13668_2022_433_Fig2_HTML.png)
Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives | SpringerLink
![TEDIGLUTIDE ..Glucagon-like peptide 2 (GLP-2) analog; protects small intestinal stem cells from radiation damage. | New Drug Approvals TEDIGLUTIDE ..Glucagon-like peptide 2 (GLP-2) analog; protects small intestinal stem cells from radiation damage. | New Drug Approvals](http://upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Teduglutide.png/800px-Teduglutide.png)
TEDIGLUTIDE ..Glucagon-like peptide 2 (GLP-2) analog; protects small intestinal stem cells from radiation damage. | New Drug Approvals
![Microorganisms | Free Full-Text | GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk Microorganisms | Free Full-Text | GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk](https://pub.mdpi-res.com/microorganisms/microorganisms-10-02061/article_deploy/html/images/microorganisms-10-02061-g001a-550.jpg?1666151991)
Microorganisms | Free Full-Text | GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
![Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice | American Journal of Physiology-Gastrointestinal and Liver Physiology Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice | American Journal of Physiology-Gastrointestinal and Liver Physiology](https://journals.physiology.org/cms/10.1152/ajpgi.00062.2020/asset/images/medium/zh3005207782r001.png)
Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice | American Journal of Physiology-Gastrointestinal and Liver Physiology
![Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system - ScienceDirect Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332223001713-ga1.jpg)
Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system - ScienceDirect
![Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy](https://c8.alamy.com/comp/DJFM9H/glucagon-like-peptide-2-glp-2-peptide-molecule-its-recombinant-analog-DJFM9H.jpg)
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy
![Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Stock Illustration - Illustration of polypeptide, glp2: 35580175 Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Stock Illustration - Illustration of polypeptide, glp2: 35580175](https://thumbs.dreamstime.com/z/glucagon-like-peptide-glp-peptide-molecule-its-recombinant-analog-teduglutide-used-to-treat-short-bowel-syndrome-orphan-35580175.jpg)